Why More Researchers Are Switching to Labii from VC-Backed ELN/LIMS Platforms Like Benchling
Last updated
Was this helpful?
Last updated
Was this helpful?
Scientific research thrives on innovation — yet many of the tools researchers rely on have stopped innovating. If you’re still using a VC-backed ELN/LIMS platform like Benchling, you might already be feeling the frustration: ever-increasing costs and stagnating features. It’s time to rethink your options.
Venture capital has fueled the rapid growth of many ELN/LIMS providers, including Benchling. But there’s a hidden cost. VC-backed companies have one primary goal: maximize returns for investors. The more money they raise, the higher the expectations for profit — and that pressure trickles down to users like you.
Over the past few years, we’ve seen this dynamic play out clearly:
Annual Price Increases: Benchling and similar platforms have consistently raised their prices year after year, far outpacing improvements to their product. Budgets are squeezed, but what are you getting in return?
Stalled Innovation: With profitability as the top priority, VC-backed platforms often focus on preserving their current offerings rather than exploring new ways to support evolving research needs. Benchling’s platform today looks much like it did several years ago — familiar, yes, but hardly keeping pace with the changing ways scientists manage and document their research.
Marketing Over Product Development: A significant portion of the investment received by these VC-backed companies goes into sales and marketing, not into improving the product itself. Just because a company is everywhere — on billboards, at conferences, in your inbox — doesn’t mean they’re building a better solution.
Scientific research isn’t static, and neither should your data management tools be. The best ELN/LIMS platforms don’t just store data — they evolve with the way science is done. From new experimental techniques to new compliance standards, innovation should be constant.
Labii was built on that philosophy. We’re not backed by venture capital, and we’re not beholden to investors. Our only obligation is to our customers and the future of scientific research. That independence lets us do what VC-backed platforms often can’t:
Continuous Innovation: We actively develop new features and reimagine how data should be documented — because we believe ELN/LIMS software should adapt to how you work, not the other way around.
Flexible, Configurable Solutions: Labii is designed to fit your workflow, not force you into rigid templates built for the masses.
Transparent, Predictable Pricing: Without the pressure to constantly increase margins, we offer fair pricing — and we don’t believe in hiking costs every year just because we can.
If you’ve never heard of Labii, it doesn’t mean Benchling is the better platform. Brand recognition is often the result of marketing budgets — not product excellence. Many of the biggest names in the industry have simply outspent their competition on advertising and outreach, not out-innovated them.
In scientific research, your choice of ELN/LIMS should be based on how well the tool meets your needs — not how often you see their logo. Don’t let branding replace critical evaluation.
Platforms like Benchling have stopped pushing the envelope. But science doesn’t stop evolving, and neither should your ELN/LIMS. Sticking with a platform that prioritizes profit and branding over real innovation holds your research back.
Labii is different. We focus on building solutions that help scientists work better today — and tomorrow. We listen closely to our customers and invest in what matters: more flexible data models, better integrations, new workflows, and cutting-edge support for scientific innovation.
If you’re tired of watching your costs rise while your software stands still, maybe it’s time to switch. Labii offers a modern, customizable alternative — one that respects your budget and evolves with your needs.
Don’t let VC priorities and flashy branding hold your research back. Choose a platform built for scientists, not shareholders.
Explore Labii today. To learn more, schedule a meeting with Labii representatives () or create an account () to try it out yourself.